Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 3Lymphoid 3Other hematologic neoplasm 2Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 413Leukemia 346Leukemia, Myeloid, Acute 289Leukemia, Lymphocytic, Chronic, B-Cell 286Lymphoma 217Myelodysplastic Syndromes 207Lymphoma, Non-Hodgkin 196Burkitt Lymphoma 160Lymphoma, Follicular 149Lymphoma, Mantle-Cell 136Lymphoma, Large B-Cell, Diffuse 135Hodgkin Disease 131Multiple Myeloma 120Lymphoma, B-Cell, Marginal Zone 118Lymphoma, Large-Cell, Immunoblastic 95Leukemia, Myelogenous, Chronic, BCR-ABL Positive 91Hematologic Neoplasms 87Myeloproliferative Disorders 85Leukemia, Myeloid, Chronic-Phase 83Leukemia, Myeloid, Accelerated Phase 80Leukemia, Myelomonocytic, Chronic 78Recurrence 72Congenital Abnormalities 68Blast Crisis 64Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 63Graft vs Host Disease 62Neoplasms, Plasma Cell 61Anemia, Refractory, with Excess of Blasts 60Primary Myelofibrosis 59Dendritic Cell Sarcoma, Interdigitating 59

Interventions

Alemtuzumab 3Cyclophosphamide 2tocilizumab 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methotrexate 1Melphalan 1Etoposide 1Dexamethasone 1Cytarabine 1Calcium Dobesilate 1Busulfan 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphohistiocytosis, Hemophagocytic × Cyclophosphamide × Other hematologic neoplasm × Clear all
NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

NCT00368355 2020-01-21

MOHEL

Baylor College of Medicine

Phase 2 Completed
46 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡